title: Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
authors.affiliation: State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, PR China.
authors.forename: Yong-Miao
authors.initials: YM
authors.lastname: Shen
authors.forename: Peng-Cheng
authors.initials: PC
authors.lastname: Lv
authors.forename: Wu
authors.initials: W
authors.lastname: Chen
authors.forename: Peng-Gang
authors.initials: PG
authors.lastname: Liu
authors.forename: Ming-Zhu
authors.initials: MZ
authors.lastname: Zhang
authors.forename: Hai-Liang
authors.initials: HL
authors.lastname: Zhu
mesh_terms: D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D066246:ErbB Receptors / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007212:Indolizines / Q000138:chemical synthesis / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology*; D020128:Inhibitory Concentration 50; D008958:Models, Molecular; D008968:Molecular Conformation
chemical_list: D000970:Antineoplastic Agents; D007212:Indolizines; C035094:indolizine; D066246:ErbB Receptors